<DOC>
	<DOCNO>NCT01004614</DOCNO>
	<brief_summary>This study conduct determine 5 mg amlodipine 3rd Orally-Disintegrating ( OD ) tablet ( new formulation ) 5 mg amlodipine 2nd OD tablet ( commercial formulation ) bioequivalent .</brief_summary>
	<brief_title>Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet</brief_title>
	<detailed_description />
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Healthy ; Body Mass Index ( BMI ) 18 28 kg/m2 ; total body weight within range 50 100 kg History regular alcohol consumption exceed 14 drinks/week Use tobacco nicotinecontaining product excess equivalent 10 cigarette per day</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>